Mano Michael 4
4 · Karyopharm Therapeutics Inc. · Filed Sep 1, 2022
Insider Transaction Report
Form 4
Mano Michael
EVP, CLO&Secretary
Transactions
- Award
Common Stock
2022-08-31+20,000→ 83,000 total - Award
Stock Option (right to buy)
2022-08-31+30,000→ 30,000 totalExercise: $5.06Exp: 2032-08-30→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as to 50% of the shares on August 31, 2023, with the remaining 50% vesting on August 31, 2024.
- [F2]This option was granted on August 31, 2022 pursuant to the Plan. The shares underlying this option vest as to 50% of the shares on August 31, 2023, with the remaining 50% vesting on August 31, 2024.